Mamma Print measures the m RNA level of 1900 different genes, whereby the expression of 70 specific genes is measured six times, in order to examine them in greater detail.
Agendia’s Mamma Print is a test which determines how aggressive a breast cancer tumour is.
Unfortunately, half of all breast cancer patients receive chemotherapy unnecessarily. It is the only test which can indicate with precision which stage your tumour is at, so that you and your surgical or medical oncologist can decide on the most appropriate treatment for your condition.
The Mamma Print result will enable your surgical or medical oncologist to determine what would be the best kind of treatment for you following your operation.
Mamma Print is carried out on tumour tissue that is fixated in formalin or fresh, which is put in an m RNA preservative immediately after the operation has taken place.